Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
about
The Recent Review of the Genitourinary Syndrome of MenopauseEtiology, diagnosis, and clinical management of vulvodyniaImmunolocalization of steroidogenic enzymes in the vaginal mucous of Galea spixii during the estrous cycle.A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapyManagement of Vaginal Atrophy: Implications from the REVIVE Survey.Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.Attitudes About Sexual Activity Among Postmenopausal Women in Different Ethnic Groups: A Cross-sectional Study in Jahrom, IranVulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures.Role of Vitamin D in urogenital health of geriatric participants.Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.Ospemifene: first global approval.Profile of ospemifene in the breast.Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause.Ospemifene in the treatment of vulvovaginal atrophy.Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society.Menopause and Sexuality.The role of local estrogen therapy in the management of pelvic floor disorders.Animal Models for the Study of Female Sexual Dysfunction.Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients.Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors.Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner.Women's expectations and experiences of hormone treatment for sexual dysfunction.A Dermatologist's Approach to Genitourinary Syndrome of Menopause.Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.Female Sexual Dysfunction and Premature Menopause with Focus on Women’s Wording
P2860
Q26781733-5758A9D0-E856-4215-864F-65129B35BC7EQ33583445-F2E41B6D-5997-42AB-9A45-64CF586223E6Q33602152-223E5FC5-7857-4D62-AD71-6E45F9DD40F9Q33605919-5940734A-5A5E-49BA-889F-2426D9AF4314Q33809618-68653EEE-5FA8-459A-B864-0F707BC82048Q35002766-7B21CA3D-DFB5-4443-855B-00963C56E7BEQ35824414-0C09E110-05C4-4603-9971-BA93A85CCD26Q36626614-D11BA326-698D-4789-A3A4-08BB7F85688FQ36762551-0ABCE9A7-F145-4B56-ACF7-EE7765BB9453Q36961194-9C6C252D-F752-4695-B9B1-F3815C59DB2FQ37721927-782EACA6-D56E-454A-B820-9FA4952887B8Q38065195-CF6B60BD-E3A0-44FB-8F16-777A6CAD867DQ38100714-40BEF238-4E23-4233-8806-186E83851B4EQ38129004-B6FF43FA-4D4F-4FDC-974A-A87232F4B1E9Q38178431-BE69E2DF-7376-4985-AE24-577DF80659ABQ38194966-0AD2CD31-961E-4A27-924E-3CFBE0C68862Q38242862-04939C01-0EAB-4B43-85A3-6E234997E8D2Q38575665-104617D6-8E99-4641-838D-280A38725E87Q38717871-297BDA66-2220-4737-AC29-C9D2D31C5BF8Q38991824-0B83EB26-5C6C-45B2-BE36-7DE22000B06FQ39161834-570539F2-6A5F-40A4-95B1-D859759D6D4BQ47636099-B90C20D1-E6D3-4E12-8B3A-B65C662836B4Q47670995-10FBE9D8-82D5-45EB-A8F9-DCFECD54E002Q49822445-31EEFBD9-F35D-4B47-8771-95F00B1C79AFQ50747648-3E4453CF-A51F-40FF-B3E9-1379C9B82CC5Q50964914-24F34A52-2AFF-4C4D-BC3C-9127C702687BQ51136922-E2DA6E16-442F-4238-B90D-DA4BC6748C8FQ53325328-D7C35278-283F-4E16-8D85-B6C2EA5ED2DFQ55060038-9D8FBDAD-7FAF-4665-B3B2-032ACF828C80Q57345846-F7963486-A2C0-488A-9031-33C873E611D1
P2860
Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of vulvovaginal atr ...... women: an up-to-date review.
@en
Management of vulvovaginal atr ...... women: an up-to-date review.
@nl
type
label
Management of vulvovaginal atr ...... women: an up-to-date review.
@en
Management of vulvovaginal atr ...... women: an up-to-date review.
@nl
prefLabel
Management of vulvovaginal atr ...... women: an up-to-date review.
@en
Management of vulvovaginal atr ...... women: an up-to-date review.
@nl
P2093
P1433
P1476
Management of vulvovaginal atr ...... women: an up-to-date review.
@en
P2093
Bruce R Carr
Karen Bradshaw
P304
P356
10.1097/GME.0B013E31821F92DF
P407
P577
2012-01-01T00:00:00Z